Positron emission tomography provides researchers and clinicians with
information on cerebral bloodflow, metabolic pathways or neurotransmis
sion systems, which may help to understand the physiopathology of move
ment disorders. Studies of the nigrostriatal dopaminergic pathway and
data on cerebral glucose metabolism contribute to discriminate between
parkinsonian syndromes. New techniques for image processing and stati
stical analysis, and brain activation studies better emphasize dysfunc
tion of cortico-subcortical neuronal networks responsible for movement
disorders, or functional modification after therapeutic action.